|
MAN2A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.57379999990937E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.937920E-03 |
| Normal-vs-Stage2 |
5.029400E-01 |
| Normal-vs-Stage3 |
1.15849999593465E-08 |
| Normal-vs-Stage4 |
2.30040000381848E-08 |
| Stage1-vs-Stage2 |
6.374200E-01 |
| Stage1-vs-Stage3 |
4.521000E-03 |
| Stage1-vs-Stage4 |
1.978820E-03 |
| Stage2-vs-Stage3 |
1.132440E-01 |
| Stage2-vs-Stage4 |
7.136500E-02 |
| Stage3-vs-Stage4 |
5.763200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.51032999999856E-05 |
| Normal-vs-AfricanAmerican |
8.1121999999989E-05 |
| Normal-vs-Asian |
8.405900E-02 |
| Caucasian-vs-AfricanAmerican |
1.741610E-01 |
| Caucasian-vs-Asian |
9.749800E-01 |
| AfricanAmerican-vs-Asian |
5.184000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.32989999999766E-05 |
| Normal-vs-Female |
4.55799999998785E-06 |
| Male-vs-Female |
7.451000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19030000000908E-06 |
| Normal-vs-Age(41-60Yrs) |
2.222900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.31589999996518E-06 |
| Normal-vs-Age(81-100Yrs) |
5.416900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.891700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.865400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.021800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.561200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.053200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.209200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.621800E-01 |
| Normal-vs-Grade 2 |
2.098000E-03 |
| Normal-vs-Grade 3 |
2.96379999997765E-06 |
| Normal-vs-Grade 4 |
2.03279999499983E-08 |
| Grade 1-vs-Grade 2 |
6.582000E-01 |
| Grade 1-vs-Grade 3 |
3.369800E-01 |
| Grade 1-vs-Grade 4 |
4.384400E-02 |
| Grade 2-vs-Grade 3 |
2.702000E-01 |
| Grade 2-vs-Grade 4 |
7.783600E-03 |
| Grade 3-vs-Grade 4 |
7.057800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.480140E-03 |
| Normal-vs-ccB subtype |
3.405600E-02 |
| ccA subtype-vs-ccB subtype |
9.390200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.039600E-04 |
| Normal-vs-N1 |
9.657700E-02 |
| N0-vs-N1 |
5.625200E-01 |
|
|
